Alemtuzumab for multiple sclerosis

Overview of attention for article published in Cochrane database of systematic reviews, June 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (57th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 77 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 3,618 followers.

Alemtuzumab for multiple sclerosis 多発性硬化症に対するアレムツズマブ #Cochrane #CochraneJapan https://t.co/OcfSSWiXAp

25 Mar 2024

Reply Repost Favourite

Ein #CochraneReview bestätigt, dass Alemtuzumab das Risiko eines Rückfalls und des Fortschreitens der Erkrankung bei schubförmig remittierender MS verringern kann. https://t.co/T66Rd2dgJA Allerdings sorgten die hohen Kosten schon vor Jahren für Aufregung:

10 Aug 2023

Reply Repost Favourite

RT @rleitepacheco: The updated version of the review 'alemtuzumab for multiple sclerosis' is now published in the Cochrane library. @Riera…

14 Jun 2023

Reply Repost Favourite

The updated version of the review 'alemtuzumab for multiple sclerosis' is now published in the Cochrane library. @RieraRachel @AnaMartimbianco https://t.co/b5s4YjFWK2 1/3 https://t.co/opSt3xbjt0

12 Jun 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.